Results 241 to 250 of about 137,923 (290)

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 51-57, March 2026.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey, Paul R. Hess, Joanne L. Intile   +2 more
wiley   +1 more source

The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma. [PDF]

Br J Haematol
Zilioli VR, Tucci A, Spina M, Merli F, Arcari A, Elderly Lymphoma Committee of the Fondazione Italiana Linfomi.   +5 more
europepmc   +1 more source

A Comparative Study of Melanocytic Tumours: Linking Portuguese Dogs and Cats to Human Cases

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 105-120, March 2026.
ABSTRACT Melanocytic tumours (MT) occur in both humans and companion animals, presenting an opportunity for comparative oncology research. Thus, this study provides a comprehensive epidemiological analysis comparing MT in Portuguese dogs, cats and humans. Data were obtained from the Portuguese National Cancer Registry (RON) (2011–2021) and Vet‐OncoNet (
Catarina Alves Pinto, Ana Isabel Ribeiro, João Niza‐Ribeiro, Carlos Alberto Palmeira de Sousa, Katia Pinello, Andreia Alexandra Ferreira Santos   +5 more
wiley   +1 more source

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma. [PDF]

Hematol Rep
Seidenfaden SC, Adams TG, Kamper P, Jespersen S, Pedersen MB.   +4 more
europepmc   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

International Journal of Cancer, Volume 158, Issue 4, Page 909-923, 15 February 2026.
What's new? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang   +17 more
wiley   +1 more source

Mantle Cell Lymphoma Mimicking Parotid Neoplasm: A Rare Case Report. [PDF]

Iran J Otorhinolaryngol
Gupta T, Yadav S, Naseem AA, Singh SK, Rashmi R.   +4 more
europepmc   +1 more source

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree. [PDF]

Cureus
Jain NP, Hirani N, Khilnani AK, Oza C, Patel K.   +4 more
europepmc   +1 more source

Lymphoma-associated hemophagocytic lymphohistiocytosis. [PDF]

Hematol Transfus Cell Ther
Marcondes TSP, Chiattone CS, Gaiolla RD.
europepmc   +1 more source

Posttransplant Lymphoproliferative Disorder (PTLD): 24 Years of Experience at a Referral Center in São Paulo, Brazil. Can Differences in Prevalence and Subtype of EBV Infection in the Population Influence the Results? A Retrospective Cohort Study. [PDF]

J Transplant
Vargas JC, Helman R, Durão MS, de Arruda EF, Afonso JE, Carraro RM, Curvelo LA, Felga GEG, Matielo CEL, Almeida PH, Pasqualin D, Stanzione R, Perrone C, Perini G, Hamerschlak N.   +14 more
europepmc   +1 more source

Second Cancer Incidence and Cause-Specific Mortality in Primary Gastrointestinal Non-Hodgkin Lymphoma Survivors: A Population-Based Cohort Study. [PDF]

Cancer Med
Wu J, Yang J, Ding Y, Wang J, Cheng X, You L, Zhao F.   +6 more
europepmc   +1 more source